Viridian Therapeutics, Inc.\DE (NASDAQ:VRDN) currently has 221 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 14,384,456 | 2,135,101 | 17.43% | $447,644,271.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 6,431,923 | 1,003,402 | 18.48% | $200,161,442.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 5,612,144 | 1,280,161 | 29.55% | $174,649,921.00 |
| Bellevue Group AG | 31 Dec, 2025 | 4,358,527 | 4,358,527 | 0.00% | $135,637,360.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 3,914,458 | 454,545 | 13.14% | $121,817,933.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 3,882,709 | 0 | 0.00% | $120,829,904.00 |
| STATE STREET CORP | 31 Dec, 2025 | 3,466,560 | 912,394 | 35.72% | $107,879,347.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 3,042,703 | 1,580,303 | 108.06% | $94,688,917.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 2,524,833 | -2,855,616 | -53.07% | $78,572,803.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 2,380,000 | 0 | 0.00% | $74,065,600.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,992,174 | 225,987 | 12.80% | $62,006,691.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 1,971,678 | 227,272 | 13.03% | $61,358,619.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 1,971,411 | 848,879 | 75.62% | $61,350,310.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,792,626 | -1,050,299 | -36.94% | $55,786,521.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 1,782,235 | -142,071 | -7.38% | $55,463,153.00 |
| Fisher Asset Management, LLC | 31 Dec, 2025 | 1,780,284 | 579,058 | 48.21% | $55,402,437.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,738,225 | 1,546,284 | 805.60% | $54,093,596.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 1,500,000 | 1,500,000 | 0.00% | $46,680,000.00 |
| LOOMIS SAYLES & CO L P | 31 Dec, 2025 | 1,481,135 | -69,193 | -4.46% | $46,092,921.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 1,470,541 | -2,957,386 | -66.79% | $45,763,236.00 |